Norfolk, VA – September 29, 2011 – Hyundai Hope on Wheels and Norfolk-area Hyundai dealers awarded Children’s Hospital of The King’s Daughters (CHKD) with a $100,000 Hope Grant to support prospective research on pain, symptoms and quality of life in children with cancer and study the impact on their caregiver. CHKD is one of 71 recipients of Hyundai Hope on Wheels’ 2011 Hope Grant program, where $7.1 million will be awarded to support research and programs in honor of National Childhood Cancer Awareness Month.
The month-long program marks Hyundai Hope on Wheels’ largest donation period to-date, and will bring the total amount that the nonprofit has committed to childhood cancer, since it first began in 1998, to $43 million.
“We, at Hyundai, are thrilled to honor National Childhood Cancer Awareness Month by donating Hope Grants to institutions that are creating new possibilities to support and help cure childhood cancer,” said John Krafcik, president and CEO of Hyundai Motor America. “Hyundai and our dealers will continue to support these doctors and institutions and bring attention to the disease that affects so many young people.”
The $100,000 Hope grant to CHKD was presented during a Hope Grant ceremony at the hospital in Norfolk on Thursday at 12:30 p.m., where children battling cancer placed their handprints in colorful paint on a canvas to represent each child’s personal triumph.
This award will fund prospective research on pain, symptoms and quality of life in children with cancer and also study the impact on their caregivers.
“We are so grateful to Hyundai for supporting this important research project so we can better understand what children with cancer experience during their treatment and how this impacts their caregiver,” said Dr. Linda Pegram, a CHKD pediatric oncologist who will be conducting the research with co-investigator Dr. Melissa Mark. “The information obtained in this study will help us more aggressively identify and treat symptoms that cause the most distress to children with cancer and their families throughout the course of treatment,” said Dr. Mark. “With more aggressive symptom management, we hope to improve quality of life and help alleviate the stress involved in caring for a child with cancer.”
For the second year in a row, Hyundai’s competitive September program allowed institutions to apply for either research or programmatic grants. The submitted proposals were then reviewed by Hyundai’s elite board of medical directors. Each of the 71 Hope Grants will help fund new pediatric cancer research projects, and will be presented during a Hope Grant ceremony that will take place at the participating institution’s campus.
“We are proud to do our part locally to help fight pediatric cancer,” said Ed Snyder, Checkered Flag Hyundai dealer. “We’re inspired by the battle these kids with cancer put up daily and it’s an honor to be able to contribute to their fight.”
For more information on Hyundai Hope on Wheels’ September Hope Grant program and the 71 winning institutions, please visit HyundaiHopeonWheels.org.
HYUNDAI MOTOR AMERICA
Hyundai Motor America, headquartered in Fountain Valley, Calif., is a subsidiary of Hyundai Motor Co. of Korea. Hyundai vehicles are distributed throughout the United States by Hyundai Motor America and are sold and serviced through more than 800 dealerships nationwide. All Hyundai vehicles sold in the U.S. are covered by the Hyundai Assurance program, which includes the 5-year/60,000-mile fully transferable new vehicle warranty, Hyundai’s 10-year/100,000-mile power train warranty, 5-years of complimentary Roadside Assistance and the Hyundai Trade-in Value Guarantee.
HYUNDAI HOPE ON WHEELS
Hyundai Hope on Wheels® is the united effort of Hyundai Motor America and its more than 800 dealers across the U.S. to raise awareness about childhood cancer and to celebrate the lives of children battling the disease. In 2011, Hope on Wheels will have committed more than $43 million in donations to pediatric cancer research since the program began in 1998. Hyundai Hope on Wheels is an independent 501(c)(3) nonprofit organization.
CHKD’S CANCER PROGRAM
CHKD follows about 500 childhood cancer patients, ranging in age from newborns to survivors in their mid 20s. More than 70 new cases are diagnosed each year. The CHKD team of pediatric oncologists, surgeons, radiation oncologists, pediatric oncology nurses and nurse practitioners provide the nation’s most up-to-date treatments through CHKD’s participation in the world’s largest cancer research consortium, the Children’s Oncology Group.